Science Explorer Back to mapMap
Discussion
Researcher · Pfizer (United States) · United States

Mehrdad Haghpassand

Mehrdad Haghpassand publishes mostly in Molecular Biology, Surgery and Oncology, on topics such as Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors and Drug Transport and Resistance Mechanisms.

OpenAlex
World rank
#2,175,334
of 7,710,434 ranked researchers
Rank in United States
#653,745
of 1,627,098
Works
16
Citations
1.3k
Citations per work
82.1
h-index
12
i10-index 13Top 65% in Molecular Biology
Mehrdad Haghpassand

What does Mehrdad Haghpassand research?

Mehrdad Haghpassand's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (38%).

Health Sciences: 7 works · 41.7% of their workMedicine: 7 works · 41.7% of their workSurgery: 4 works · 25.0% of their workOncology: 2 works · 10.4% of their workNeurology: 1 works · 6.3% of their workLife Sciences: 6 works · 37.6% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 37.6% of their workMolecular Biology: 5 works · 29.2% of their workBiochemistry: 1 works · 4.2% of their workCancer Research: 1 works · 4.2% of their workEverything else: 3 works · 20.7% of their workTHEIR WORKMehrdadHaghpassand16works
Life Sciences38%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine741.7%
    1. Biochemistry, Genetics and Molecular Biology637.6%
  3. Everything else320.7%
  1. 1Molecular Biology29% of their works
  2. 2Surgery25% of their works
  3. 3Oncology10% of their works
  4. 4Neurology6% of their works
  5. 5Cancer Research4% of their works
  6. 6Biochemistry4% of their works

Research topics

Which keywords describe Mehrdad Haghpassand's research?

The keywords of their largest research topics: Metabolism, Nuclear Receptors, Cholesterol, Atherosclerosis, LXR, Peroxisome Proliferator-Activated Receptors, PPARs and ATP-dependent Transporters.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Metabolism152 topics
  2. Nuclear Receptors122 topics
  3. Cholesterol102 topics
  4. Atherosclerosis81 topic
  5. LXR81 topic
  6. PPARs71 topic
  7. Peroxisome Proliferator-Activated Receptors71 topic
  8. ATP-dependent Transporters51 topic
  9. Multidrug Resistance51 topic
  10. Statins52 topics
  11. Cardiovascular Disease Prevention31 topic
  12. Cholesterol-lowering31 topic
  13. AMP-Activated Protein Kinase21 topic
  14. Fatty Acid Synthase21 topic
  15. Lipid Droplets21 topic
  16. Lipid Metabolism21 topic
  17. Metformin21 topic
  18. Neurofibromatosis21 topic
  19. Triacylglycerol Synthesis21 topic
  20. Tumor Suppressor21 topic

Where does Mehrdad Haghpassand work?

Mehrdad Haghpassand's main affiliation in the publication record is Pfizer (United States), United States.

How many publications and citations does Mehrdad Haghpassand have?

OpenAlex counts 16 works and 1,313 citations for Mehrdad Haghpassand, an h-index of 12, ranking #2,175,334 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mehrdad Haghpassand. Posts are plain text and can be reported.